Quality of Life After Radiofrequency Ablation of Pancreatic Cancer

Quality of Life After Intraoperative Radiofrequency Ablation of Pancreatic Cancer

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02637596

Enrollment

Registered

2015-12-22

Start date

2013-02-28

Completion date

2015-12-31

Last updated

2015-12-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic Cancer

Brief summary

A prospective clinical study evaluating quality of life (QoL) in pancreatic cancer patients treated with intraoperative radiofrequency ablation (RFA).

Interventions

PROCEDURERadiofrequency ablation

After laparotomy, intraoperative IOUS quided RFA of primary tumor was performed.

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* histologically proved locally advanced or metastatic pancreatic cancer. Patients with histologically proved resectable pancreatic cancer with low Karnofsky index. informed consent

Exclusion criteria

* cystic tumor age under 18

Design outcomes

Primary

Measure	Time frame	Description
Quality of life after RFA of pancreatic cancer	3 years	Quality of life will be evaluated using EORTC C 30 and pan 26 questionaire preoperatively and three months after RFA

Secondary

Measure	Time frame	Description
3- months perioperative morbidity and mortality	3 years	Three months morbidity and mortality will be evaluated using Dindo-Clavien classification

Other

Measure	Time frame
Overall Survival	3 years

Countries

Czechia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026